These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 33478183)

  • 1. [Expression and Diagnostic Value of NPTX1 in Thymoma Patients].
    Du X; Yu L; Yang L; Cao D; Zhang Y
    Zhongguo Fei Ai Za Zhi; 2021 Jan; 24(1):1-6. PubMed ID: 33478183
    [TBL] [Abstract][Full Text] [Related]  

  • 2. NPTX1 is a novel epigenetic regulation gene and associated with prognosis in lung cancer.
    Zhou C; Qin Y; Xie Z; Zhang J; Yang M; Li S; Chen R
    Biochem Biophys Res Commun; 2015 Mar; 458(2):381-6. PubMed ID: 25646694
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vascular architecture as a diagnostic marker for differentiation of World Health Organization thymoma subtypes and thymic carcinoma.
    Pfister F; Hussain H; Belharazem D; Busch S; Simon-Keller K; Becker D; Pfister E; Rieker R; Ströbel P; Marx A
    Histopathology; 2017 Apr; 70(5):693-703. PubMed ID: 27791295
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An immunohistochemical panel consisting of EZH2, C-KIT, and CD205 is useful for distinguishing thymic squamous cell carcinoma from type B3 thymoma.
    Kim BS; Kim JK; Kang CH; Kim YT; Jung KC; Won JK
    Pathol Res Pract; 2018 Mar; 214(3):343-349. PubMed ID: 29487009
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multislice computed tomography performance in differential diagnosis of high-density thymic cyst and thymoma in lesions less than 3 cm.
    Zhonggao J; YiJiao W; Yongfeng W; Zhitao P; Jun W; Diansheng L; Bibo H; Yinhua J; Jianjun Z
    Thorac Cancer; 2018 Oct; 9(10):1300-1304. PubMed ID: 30133184
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The evaluation of immunohistochemical markers and thymic cortical microenvironmental cells in distinguishing thymic carcinoma from type b3 thymoma or lung squamous cell carcinoma.
    Hayashi A; Fumon T; Miki Y; Sato H; Yoshino T; Takahashi K
    J Clin Exp Hematop; 2013; 53(1):9-19. PubMed ID: 23801129
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of calretinin and other mesothelioma-related markers in thymic carcinoma and thymoma.
    Pan CC; Chen PC; Chou TY; Chiang H
    Hum Pathol; 2003 Nov; 34(11):1155-62. PubMed ID: 14652817
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Value of CT spectral imaging in the differential diagnosis of thymoma and mediastinal lymphoma.
    Xie Y; Zhang S; Liu J; Liang X; Zhang X; Zhang Y; Zhang Z; Zhou J
    Br J Radiol; 2019 Mar; 92(1095):20180598. PubMed ID: 30507309
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnostic utility of thymic epithelial markers CD205 (DEC205) and Foxn1 in thymic epithelial neoplasms.
    Nonaka D; Henley JD; Chiriboga L; Yee H
    Am J Surg Pathol; 2007 Jul; 31(7):1038-44. PubMed ID: 17592270
    [TBL] [Abstract][Full Text] [Related]  

  • 10. miR-139-5p mediates the palmitate-induced inhibition of insulin secretion by targeting neuronal pentraxin 1 in INS-1 cells.
    Zhang K; Zhang Y; Chen C; Yuan Y; Jiang X; Yuan X; Wang Y
    Acta Biochim Biophys Sin (Shanghai); 2021 Jul; 53(8):1017-1026. PubMed ID: 34142698
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Argyrophilic nucleolar organizer regions in cells of thymoma and thymic carcinoma: correlation with DNA ploidy and clinicopathologic characteristics.
    Lee YC; Chern JH; Pan CC; Chang SC; Perng RP
    Chest; 1999 Apr; 115(4):1115-9. PubMed ID: 10208217
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression and mutation statuses of epidermal growth factor receptor in thymic epithelial tumors.
    Suzuki E; Sasaki H; Kawano O; Endo K; Haneda H; Yukiue H; Kobayashi Y; Yano M; Fujii Y
    Jpn J Clin Oncol; 2006 Jun; 36(6):351-6. PubMed ID: 16762968
    [TBL] [Abstract][Full Text] [Related]  

  • 13. DNA methylation of GHSR, GNG4, HOXD9 and SALL3 is a common epigenetic alteration in thymic carcinoma.
    Kishibuchi R; Kondo K; Soejima S; Tsuboi M; Kajiura K; Kawakami Y; Kawakita N; Sawada T; Toba H; Yoshida M; Takizawa H; Tangoku A
    Int J Oncol; 2020 Jan; 56(1):315-326. PubMed ID: 31746370
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of proteasome subunit β5t in thymic epithelial tumors.
    Yamada Y; Tomaru U; Ishizu A; Kiuchi T; Marukawa K; Matsuno Y; Kasahara M
    Am J Surg Pathol; 2011 Sep; 35(9):1296-304. PubMed ID: 21836487
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thymic carcinoma arising in thymoma is associated with alterations in immunohistochemical profile.
    Kuo TT; Chan JK
    Am J Surg Pathol; 1998 Dec; 22(12):1474-81. PubMed ID: 9850173
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vivo and in vitro expression of somatostatin receptors in two human thymomas with similar clinical presentation and different histological features.
    Ferone D; Kwekkeboom DJ; Pivonello R; Bogers ADColao A; Lamberts SW; van Hagen PM; Hofland LJ
    J Endocrinol Invest; 2001; 24(7):522-8. PubMed ID: 11508787
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pathological Findings in Myasthenia Gravis Patients with Thymic Hyperplasia and Thymoma.
    Chen P; Wang YP; Mou DL; Li ZY; Qu QM; Wang HY; Deng Y; Li XF; Wang T; Xu XH; Zhao G
    Pathol Oncol Res; 2018 Jan; 24(1):67-74. PubMed ID: 28299711
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of cathepsins V and S in thymic epithelial tumors.
    Kiuchi S; Tomaru U; Ishizu A; Imagawa M; Kiuchi T; Iwasaki S; Suzuki A; Otsuka N; Deguchi T; Shimizu T; Marukawa K; Matsuno Y; Kasahara M
    Hum Pathol; 2017 Feb; 60():66-74. PubMed ID: 27771373
    [TBL] [Abstract][Full Text] [Related]  

  • 19. As a downstream target of the AKT pathway, NPTX1 inhibits proliferation and promotes apoptosis in hepatocellular carcinoma.
    Zhao Y; Yu Y; Zhao W; You S; Feng M; Xie C; Chi X; Zhang Y; Wang X
    Biosci Rep; 2019 Jun; 39(6):. PubMed ID: 31113871
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interleukin-8 as a candidate for thymoma identification and recurrence surveillance.
    Gao S; Jiang J; Jin C; Gao J; Xiong D; Yang P; Cui S; Yang W; Leng Q; Dong J; Chen G; Liu J; Wang L; Ke A; Wang H; Ding J
    Nat Commun; 2020 Sep; 11(1):4881. PubMed ID: 32985506
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.